| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.057 | 0.2 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.2 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.2 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | 0.065 | 0.2 |